Clinical Trial Update: Early Aldosterone Blockade in Acute Heart Failure: An Exploratory Safety Study [Phase 2]

View source ↗

Summary

The Phase 2 exploratory safety study of early aldosterone blockade in acute heart failure was withdrawn. No results are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Indiana University | Conditions: Acute Heart Failure | Phase 2 | Status: WITHDRAWN